Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Erratum to "Update of the 2021 recommendations for the management and follow-up of adult asthmatic patients under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version" [Rev. Mal. Respir. 38 (2021) 1048-1083]].
Raherison-Semjen C, Guilleminault L, Billiart I, Chenivesse C, De Oliveira A, Izadifar A, Lorenzo A, Nocent C, Oster JP, Padovani M, Perez T, Russier M, Steinecker M, Didier A. Raherison-Semjen C, et al. Among authors: russier m. Rev Mal Respir. 2022 Feb;39(2):188-189. doi: 10.1016/j.rmr.2022.01.001. Epub 2022 Jan 25. Rev Mal Respir. 2022. PMID: 35090791 French. No abstract available.
[Update of the 2021 recommendations for the management and follow-up of adult asthmatic patients under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version].
Raherison-Semjen C, Guilleminault L, Billiart I, Chenivesse C, De Oliveira A, Izadifar A, Lorenzo A, Nocent C, Oster JP, Padovani M, Perez T, Russier M, Steinecker M, Didier A. Raherison-Semjen C, et al. Among authors: russier m. Rev Mal Respir. 2021 Dec;38(10):1048-1083. doi: 10.1016/j.rmr.2021.08.002. Epub 2021 Nov 17. Rev Mal Respir. 2021. PMID: 34799211 French. No abstract available.
[Updated guidelines for management of asthmatic patients (from 12 years and older). Short version].
Raherison-Semjen C, Guilleminault L, Billiart I, Chenivesse C, De Oliveira A, Izadifar A, Lorenzo A, Nocent C, Oster JP, Padovani M, Perez T, Russier M, Steinecker M, Didier A. Raherison-Semjen C, et al. Among authors: russier m. Rev Mal Respir. 2021 Dec;38(10):e1-e13. doi: 10.1016/j.rmr.2021.08.004. Epub 2021 Nov 26. Rev Mal Respir. 2021. PMID: 34840037 French. No abstract available.
[Erratum to "Updated guidelines for management of asthmatic patients (from 12 years and older). Short version" [Rev. Mal. Respir. 38 (2021) e1-e13]].
Raherison-Semjen C, Guilleminault L, Billiart I, Chenivesse C, De Oliveira A, Izadifar A, Lorenzo A, Nocent C, Oster JP, Padovani M, Perez T, Russier M, Steinecker M, Didier A. Raherison-Semjen C, et al. Among authors: russier m. Rev Mal Respir. 2022 Feb;39(2):e33-e34. doi: 10.1016/j.rmr.2022.01.002. Epub 2022 Jan 25. Rev Mal Respir. 2022. PMID: 35090792 French. No abstract available.
De-labelling severe asthma diagnosis: the challenge of DIPNECH.
Hurabielle C, Taillé C, Prévot G, Russier M, Didier A, Girodet PO, Colombat M, Mazières J, Guilleminault L. Hurabielle C, et al. Among authors: russier m. ERJ Open Res. 2022 Feb 7;8(1):00485-2021. doi: 10.1183/23120541.00485-2021. eCollection 2022 Jan. ERJ Open Res. 2022. PMID: 35211620 Free PMC article.
Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A). Short version.
Raherison-Semjen C, Guilleminault L, Billiart I, Chenivesse C, De Oliveira A, Izadifar A, Lorenzo A, Nocent C, Oster JP, Padovani M, Perez T, Russier M, Steinecker M, Didier A. Raherison-Semjen C, et al. Among authors: russier m. Respir Med Res. 2022 May;81:100898. doi: 10.1016/j.resmer.2022.100898. Epub 2022 May 5. Respir Med Res. 2022. PMID: 35526320
Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study.
Guilleminault L, Camus C, Raherison-Semjen C, Capdepon A, Bourdin A, Bonniaud P, Fry S, Devouassoux G, Blanc FX, Pison C, Dupin C, Khayath N, Courdeau J, Valcke-Brossollet J, Nocent-Ejnaini C, Rolland F, Lamandi C, Proust A, Ozier A, Portel L, Gaspard W, Roux-Claude P, Beurnier A, Martinez S, Dot JM, Hennegrave F, Vignal G, Auvray E, Paleiron N, Just N, Miltgen J, Russier M, Olivier C, Taillé C, Didier A. Guilleminault L, et al. Among authors: russier m. Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231202749. doi: 10.1177/17534666231202749. Ther Adv Respir Dis. 2023. PMID: 37966015 Free PMC article.
Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series.
Dupin C, Valéry S, Guilleminault L, Devouassoux G, Merveilleau M, Russier M, Mourin G, Pradelli J, Bonniaud P, Le Brun M, Ebstein E, Juge PA, Lillo-Lelouet A, Taillé C. Dupin C, et al. Among authors: russier m. ERJ Open Res. 2024 Feb 26;10(1):00935-2023. doi: 10.1183/23120541.00935-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38410709 Free PMC article.
Anti-IL-4R versus anti-IL-5/5R after anti-IL-5/5R failure in asthma: An emulated target trial.
Valery S, Simon-Tillaux N, Devouassoux G, Bonniaud P, Beurnier A, Boudjemaa A, Chenivesse C, Bourdin A, Gauquelin L, Guillo S, Taillé C, Estellat C; RAMSES Study Group. Valery S, et al. J Allergy Clin Immunol. 2024 Oct;154(4):922-932. doi: 10.1016/j.jaci.2024.05.023. Epub 2024 Jun 6. J Allergy Clin Immunol. 2024. PMID: 38848878 Clinical Trial.
75 results